PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 90 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $18,000 | +38.5% | 29,000 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | -97.6% | 29,000 | -94.4% | 0.00% | -100.0% |
| Q1 2016 | $543,000 | -22.5% | 517,456 | +117.9% | 0.01% | -30.8% |
| Q4 2015 | $701,000 | -5.1% | 237,456 | +1.5% | 0.01% | -13.3% |
| Q3 2015 | $739,000 | +332.2% | 233,856 | +710.4% | 0.02% | +400.0% |
| Q2 2015 | $171,000 | -44.5% | 28,856 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $308,000 | +12.0% | 28,856 | -1.4% | 0.01% | 0.0% |
| Q4 2014 | $275,000 | +37.5% | 29,256 | +12.3% | 0.01% | +20.0% |
| Q3 2014 | $200,000 | -35.9% | 26,056 | -77.3% | 0.01% | -54.5% |
| Q3 2013 | $312,000 | -6.9% | 114,800 | +23.6% | 0.01% | -15.4% |
| Q2 2013 | $335,000 | – | 92,849 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |